Grant opportunity for promising therapies and drug-delivery mechanisms to accelerate the development of gene-based therapies for people with cystic fibrosis.
MOIRe is Mochida Pharmaceutical's open innovation program for drug discovery research based on proposals from academic researchers.
The Translational Research Grant program from NCBC supports commercial development of university research with up to $110K awards. Due 8/23.
OTC invites you to the annual celebration and showcase of Duke inventors. Tuesday, November 28th, 2023 | 4:30-7PM.
BioTools Innovator matches industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.
Duke investigators can apply to this program. CSL Behring will provide funding for approved projects up to $400K over a two-year period.
$100K award for novel approaches to treat rare diseases: neurological disorders, developmental and metabolic disorders, and rare cancers.
Artificial intelligence is everywhere nowadays, including in research and technology commercialization. Hear experts parse the landscape.
Join NCBC for an information session and lunch discussing funding opportunities in the life sciences specifically for Duke researchers.